Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2005
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
M Brada, S Ashley, A Dowe, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
M Bower, E S Newlands, N M Bleehen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 6, 1999
Comparison of a multi-leaf collimator with conformal blocks for the delivery of stereotactically guided conformal radiotherapy
E J Adams, V P Cosgrove, S F Shepherd, et al.
Clinical Endocrinology
|
June 10, 2000
Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience
R Jalali, M Brada, J R Perks, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 3, 2001
Growth hormone treatment of children with brain tumors and risk of tumor recurrence
A J Swerdlow, R E Reddingius, C D Higgins, et al.
Cancer
|
September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
G M Mead, N M Bleehen, A Gregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
October 30, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors
M Štork, J Kotašková, E Ondroušková, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2005
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
M Brada, S Ashley, A Dowe, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
M Bower, E S Newlands, N M Bleehen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 6, 1999
Comparison of a multi-leaf collimator with conformal blocks for the delivery of stereotactically guided conformal radiotherapy
E J Adams, V P Cosgrove, S F Shepherd, et al.
Clinical Endocrinology
|
June 10, 2000
Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience
R Jalali, M Brada, J R Perks, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 3, 2001
Growth hormone treatment of children with brain tumors and risk of tumor recurrence
A J Swerdlow, R E Reddingius, C D Higgins, et al.
Cancer
|
September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
G M Mead, N M Bleehen, A Gregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
October 30, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors
M Štork, J Kotašková, E Ondroušková, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
Page
of 16